HighGravityDataElevance Health — Jan 23, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001156039-25-000007
Showing in the filing
Dividend
“$1.71 per share”
Period
Q1 FY2025
Measure
Declared action
Source
Prose
All guidance in this release · 31
Dividend for Q1 FY2025
“$1.71 per share”
Projected FY 2025 GAAP diluted EPS for FY2025
“$30.40 to $31.10”
Shareholders' earnings per diluted share for FY2025
“$30.40 to $31.10”
Adjusted shareholders' earnings per diluted … for FY2025
“$34.15 to $34.85”
Projected FY 2025 adjusted diluted EPS for FY2025
“$34.15 to $34.85”
Premium Revenue for FY2025
“Low double digit growth”
Product Revenue for FY2025
“Low single digit growth”
Service Fees for FY2025
“Approximately flat”
Total Operating Revenue for FY2025
“High single to low double digit growth”
Benefit Expense Ratio for FY2025
“89.1% +/- 50 bps”
Adjusted Operating Expense Ratio for FY2025
“10.4% +/- 50 bps”
Adjusted Operating Gain for FY2025
“$9.55 - $9.85 billion”
Net Investment income for FY2025
“$1,875 million”
Interest Expense for FY2025
“($1,475) million”
Amortization of Intangible Assets for FY2025
“($580) million”
Adjusted Effective Tax Rate for FY2025
“22.0% - 24.0%”
Diluted Shares for FY2025
“225 - 226 million”
Operating Cash Flow for FY2025
“Approximately $8.0 billion”
Operating Revenue Growth Rate: Health Benefits for FY2025
“High single digit growth”
Operating Revenue Growth Rate: Carelon Servi… for FY2025
“Greater than 50% growth”
GAAP Operating Margin vs. 2024: Health Benef… for FY2025
“(50) - (25) bps”
GAAP Operating Margin vs. 2024: CarelonRx for FY2025
“0 - 20 bps”
GAAP Operating Margin vs. 2024: Carelon Serv… for FY2025
“(100) - (50) bps”
Year-End Medical Enrollment: Commercial Fee-… for FY2025
“27,300 - 27,600”
Year-End Medical Enrollment: Commercial Risk… for FY2025
“5,150 - 5,350”
Year-End Medical Enrollment: Medicaid for FY2025
“8,600 - 8,900”
Year-End Medical Enrollment: Medicare Advant… for FY2025
“2,200 - 2,250”
Year-End Medical Enrollment: Medicare Supple… for FY2025
“Approximately 850”
Year-End Medical Enrollment: Federal Employe… for FY2025
“Approximately 1,650”
Year-End Medical Enrollment: Risk-Based for FY2025
“18,450 - 19,000”
Year-End Medical Enrollment: Total for FY2025
“45,750 - 46,600”
Exhibit 99.1 · the passage around this item
… earlier in the release
Similarly, on an adjusted basis, operating gain was $3.1 billion, an increase of $0.4 billion, or 17 percent. 4 Quarterly Dividend On January 22, 2025, the Audit Committee of the Company's Board of Directors declared a first quarter 2025 dividend to shareholders of $1.71 per share. The first quarter dividend is payable on March 25, 2025, to shareholders of record at the close of business on March 10, 2025. About Elevance Health Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 112 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn. Conference Call and Webcast Management will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time (“EST”) to discuss the company’s fourth quarter and full year 2024 results and 2025 outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers: 888-947-9963 (Domestic) 866-405-7292 (Domestic Replay) 312-470-0178 (International) 203-369-0604 (Internat
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.